VIVO logo

Meridian Bioscience (VIVO) EBIT

Annual EBIT

$55.51 M
-$36.82 M-39.88%

September 30, 2022

Summary

Performance

1-Year Change

-39.88%

3-Year Change

+65.68%

5-Year Change

+45.8%

15-Year Change

+45.8%

VIVO EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$92.33 M
VIVO annual earnings before interest & taxes is currently -39.88% below its historical high of $92.33 million

3-Year Low

$55.51 M
VIVO annual earnings before interest & taxes is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Sep 30, 2022
VIVO previous annual earnings announcement was published on Sep 30, 2022

Next Annual Earnings Report Date

N/A
VIVO next annual earnings announcement has not yet been scheduled

OtherVIVOprofitabilitymetrics:

Annual Revenue

$333.02 M
VIVO annual revenue is $333.02 million

Annual Net Income

$42.46 M
VIVO annual net profit is $42.46 million

Annual EBITDA

$72.02 M
VIVO annual EBITDA is $72.02 million

Annual EPS

$0.96
VIVO annual earnings per share is $0.96

Quarterly EBIT

$4.85 M
+$11.20 M+176.47%

September 30, 2022

Summary

Performance

3-Month Change

+176.47%

1-Year Change

-41.42%

3-Year Change

-21%

5-Year Change

-46.3%

VIVO Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$36.88 M
VIVO quarterly earnings before interest & taxes is currently -86.84% below its historical high of $36.88 million

3-Year Low

-$6.35 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
VIVO previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
VIVO next earnings announcement has not yet been scheduled

OtherVIVOprofitabilitymetrics:

Quarterly Revenue

$65.67 M
VIVO quarterly revenue is $65.67 million

Quarterly Net Income

$5.71 M
VIVO quarterly net profit is $5.71 million

Quarterly EBITDA

$8.92 M
VIVO quarterly EBITDA is $8.92 million

Quarterly EPS

$0.13
VIVO quarterly earnings per share is $0.13

TTM EBIT

$55.51 M
-$3.43 M-5.82%

September 30, 2022

Summary

Performance

3-Month Change

-5.82%

1-Year Change

-39.88%

3-Year Change

+102.16%

5-Year Change

+102.16%

VIVO TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$112.26 M
VIVO TTM earnings before interest & taxes is currently -50.56% below its historical high of $112.26 million

3-Year Low

$55.51 M
VIVO TTM earnings before interest & taxes is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
VIVO previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
VIVO next earnings announcement has not yet been scheduled

OtherVIVOprofitabilitymetrics:

TTM Revenue

$333.02 M
VIVO TTM revenue is $333.02 million

TTM Net Income

$42.46 M
VIVO TTM net profit is $42.46 million

TTM EBITDA

$72.02 M
VIVO TTM EBITDA is $72.02 million

TTM EPS

$0.96
VIVO TTM earnings per share is $0.96

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

Annual EBIT

$55.51 M
VIVO annual earnings before interest & taxes is $55.51 million

Annual Revenue

$333.02 M
VIVO annual revenue is $333.02 million

Annual Cost Of Goods Sold

$144.66 M
VIVO annual cost of goods sold is $144.66 million

Annual Operating Expenses

$112.41 M
VIVO annual total operating expenses is $112.41 million

VIVO EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-39.9%-41.4%-39.9%
3 y3 years+65.7%-21.0%+102.2%
5 y5 years+45.8%-46.3%+102.2%

VIVO EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-39.9%at low-86.8%-230.8%-31.5%at low
5 y5-year-39.9%-39.6%-86.8%-230.8%-50.6%-50.5%
alltimeall time-39.9%-111.2%-86.8%-230.8%-50.6%-102.2%

Meridian Bioscience EBIT History

DateAnnualQuarterlyTTM
Sep 2022
$55.51 M(-39.9%)
$4.85 M(-176.5%)
$55.51 M(-5.8%)
Jun 2022
-
-$6.35 M(-117.2%)
$58.94 M(-27.3%)
Mar 2022
-
$36.88 M(+83.3%)
$81.02 M(+4.3%)
Dec 2021
-
$20.12 M(+142.9%)
$77.67 M(-15.9%)
Sep 2021
$92.33 M(+49.1%)
$8.28 M(-47.4%)
$92.33 M(-0.1%)
Jun 2021
-
$15.74 M(-53.1%)
$92.42 M(-17.7%)
Mar 2021
-
$33.52 M(-3.6%)
$112.26 M(+22.1%)
Dec 2020
-
$34.78 M(+315.2%)
$91.91 M(+48.4%)
Sep 2020
$61.92 M(+84.8%)
$8.38 M(-76.5%)
$61.92 M(+3.7%)
Jun 2020
-
$35.58 M(+169.9%)
$59.69 M(+92.3%)
Mar 2020
-
$13.18 M(+175.0%)
$31.04 M(+13.1%)
Dec 2019
-
$4.79 M(-22.0%)
$27.46 M(-18.0%)
Sep 2019
$33.50 M(+5.0%)
$6.14 M(-11.3%)
$33.50 M(-3.2%)
Jun 2019
-
$6.93 M(-27.8%)
$34.61 M(-5.6%)
Mar 2019
-
$9.59 M(-11.5%)
$36.68 M(+5.7%)
Dec 2018
-
$10.84 M(+49.5%)
$34.69 M(+8.7%)
Sep 2018
$31.90 M(-16.2%)
$7.25 M(-19.4%)
$31.90 M(-5.3%)
Jun 2018
-
$8.99 M(+18.3%)
$33.69 M(+16.0%)
Mar 2018
-
$7.60 M(-5.6%)
$29.05 M(-19.4%)
Dec 2017
-
$8.05 M(-10.9%)
$36.04 M(-5.3%)
Sep 2017
$38.07 M(-26.1%)
$9.04 M(+107.6%)
$38.07 M(-0.4%)
Jun 2017
-
$4.35 M(-70.2%)
$38.21 M(-19.9%)
Mar 2017
-
$14.60 M(+44.8%)
$47.69 M(-0.5%)
Dec 2016
-
$10.08 M(+9.8%)
$47.92 M(-7.0%)
Sep 2016
$51.54 M(-6.4%)
$9.18 M(-33.6%)
$51.54 M(-7.1%)
Jun 2016
-
$13.83 M(-6.8%)
$55.50 M(-0.9%)
Mar 2016
-
$14.84 M(+8.3%)
$55.98 M(-1.2%)
Dec 2015
-
$13.70 M(+4.3%)
$56.67 M(+1.9%)
Sep 2015
$55.06 M(+5.7%)
$13.14 M(-8.2%)
$55.64 M(+2.7%)
Jun 2015
-
$14.30 M(-7.9%)
$54.19 M(+2.2%)
Mar 2015
-
$15.53 M(+22.6%)
$53.01 M(-0.3%)
Dec 2014
-
$12.67 M(+8.4%)
$53.15 M(+2.0%)
Sep 2014
$52.11 M(-9.1%)
$11.68 M(-11.0%)
$52.11 M(-3.0%)
Jun 2014
-
$13.13 M(-16.2%)
$53.70 M(-4.6%)
Mar 2014
-
$15.67 M(+34.7%)
$56.26 M(+0.7%)
Dec 2013
-
$11.63 M(-12.4%)
$55.85 M(-2.6%)
Sep 2013
$57.31 M(+13.9%)
$13.27 M(-15.5%)
$57.31 M(+2.2%)
Jun 2013
-
$15.70 M(+2.9%)
$56.09 M(+5.1%)
Mar 2013
-
$15.25 M(+16.5%)
$53.37 M(+0.4%)
Dec 2012
-
$13.09 M(+8.6%)
$53.15 M(+5.6%)
Sep 2012
$50.31 M(+20.3%)
$12.05 M(-7.1%)
$50.31 M(+0.8%)
Jun 2012
-
$12.98 M(-13.7%)
$49.90 M(+6.1%)
Mar 2012
-
$15.03 M(+46.6%)
$47.05 M(+9.5%)
Dec 2011
-
$10.25 M(-11.9%)
$42.98 M(+2.8%)
Sep 2011
$41.82 M(-1.3%)
$11.64 M(+14.9%)
$41.82 M(+6.6%)
Jun 2011
-
$10.13 M(-7.6%)
$39.23 M(-0.8%)
Mar 2011
-
$10.96 M(+20.6%)
$39.55 M(+4.9%)
Dec 2010
-
$9.09 M(+0.5%)
$37.71 M(-11.0%)
Sep 2010
$42.38 M(-13.1%)
$9.05 M(-13.4%)
$42.38 M(-8.7%)
Jun 2010
-
$10.45 M(+14.5%)
$46.41 M(-4.3%)
Mar 2010
-
$9.13 M(-33.7%)
$48.50 M(-3.7%)
Dec 2009
-
$13.76 M(+5.1%)
$50.38 M(+3.3%)
Sep 2009
$48.78 M(+10.0%)
$13.09 M(+4.4%)
$48.78 M(+3.5%)
Jun 2009
-
$12.53 M(+13.9%)
$47.11 M(+3.4%)
Mar 2009
-
$11.01 M(-9.5%)
$45.58 M(+0.6%)
Dec 2008
-
$12.16 M(+6.5%)
$45.31 M(+2.2%)
Sep 2008
$44.35 M(+26.6%)
$11.42 M(+3.8%)
$44.35 M(+6.7%)
Jun 2008
-
$11.00 M(+2.4%)
$41.56 M(+3.8%)
Mar 2008
-
$10.74 M(-4.1%)
$40.05 M(+5.0%)
Dec 2007
-
$11.19 M(+29.6%)
$38.15 M(+9.0%)
Sep 2007
$35.03 M(+30.3%)
$8.63 M(-9.0%)
$35.02 M(+5.4%)
Jun 2007
-
$9.49 M(+7.4%)
$33.23 M(+8.5%)
Mar 2007
-
$8.83 M(+9.6%)
$30.64 M(+6.5%)
Dec 2006
-
$8.06 M(+17.6%)
$28.78 M(+7.0%)
Sep 2006
$26.89 M(+32.3%)
$6.85 M(-0.6%)
$26.89 M(+3.5%)
Jun 2006
-
$6.89 M(-1.2%)
$25.99 M(+4.8%)
Mar 2006
-
$6.98 M(+13.1%)
$24.81 M(+7.7%)
Dec 2005
-
$6.17 M(+3.7%)
$23.03 M(+13.3%)
Sep 2005
$20.32 M(+38.7%)
$5.95 M(+4.3%)
$20.32 M(+9.7%)
Jun 2005
-
$5.71 M(+9.8%)
$18.54 M(+14.5%)
Mar 2005
-
$5.20 M(+49.9%)
$16.19 M(+8.1%)
Dec 2004
-
$3.47 M(-16.7%)
$14.98 M(+2.2%)
Sep 2004
$14.66 M(+14.6%)
$4.16 M(+23.7%)
$14.66 M(+7.2%)
Jun 2004
-
$3.37 M(-15.4%)
$13.67 M(+2.2%)
Mar 2004
-
$3.98 M(+26.5%)
$13.37 M(+1.5%)
Dec 2003
-
$3.15 M(-0.9%)
$13.18 M(+3.0%)
DateAnnualQuarterlyTTM
Sep 2003
$12.79 M(+28.0%)
$3.17 M(+3.5%)
$12.79 M(+10.9%)
Jun 2003
-
$3.07 M(-18.9%)
$11.53 M(+1.1%)
Mar 2003
-
$3.78 M(+37.0%)
$11.40 M(+9.2%)
Dec 2002
-
$2.76 M(+44.4%)
$10.44 M(+4.5%)
Sep 2002
$9.99 M(-261.3%)
$1.91 M(-35.0%)
$9.99 M(-20.9%)
Jun 2002
-
$2.94 M(+4.1%)
$12.63 M(+12.5%)
Mar 2002
-
$2.83 M(+22.1%)
$11.23 M(+56.2%)
Dec 2001
-
$2.31 M(-49.1%)
$7.19 M(+140.6%)
Sep 2001
-$6.20 M(-161.0%)
$4.55 M(+196.0%)
$2.99 M(-437.6%)
Jun 2001
-
$1.54 M(-226.8%)
-$885.00 K(-192.8%)
Mar 2001
-
-$1.21 M(-35.7%)
$954.00 K(-82.9%)
Dec 2000
-
-$1.89 M(-379.0%)
$5.57 M(-45.2%)
Sep 2000
$10.15 M(-11.3%)
$676.00 K(-80.0%)
$10.15 M(-18.4%)
Jun 2000
-
$3.38 M(-0.7%)
$12.45 M(+2.6%)
Mar 2000
-
$3.40 M(+25.9%)
$12.13 M(-1.3%)
Dec 1999
-
$2.70 M(-9.2%)
$12.29 M(+7.0%)
Sep 1999
$11.44 M(+36.2%)
$2.97 M(-3.0%)
$11.49 M(+18.2%)
Jun 1999
-
$3.06 M(-13.8%)
$9.72 M(+7.3%)
Mar 1999
-
$3.55 M(+87.1%)
$9.05 M(+10.4%)
Dec 1998
-
$1.90 M(+58.3%)
$8.20 M(+1.2%)
Sep 1998
$8.40 M(-15.2%)
$1.20 M(-50.0%)
$8.10 M(-21.4%)
Jun 1998
-
$2.40 M(-11.1%)
$10.30 M(-3.7%)
Mar 1998
-
$2.70 M(+50.0%)
$10.70 M(+7.0%)
Dec 1997
-
$1.80 M(-47.1%)
$10.00 M(+1.0%)
Sep 1997
$9.90 M(+16.5%)
$3.40 M(+21.4%)
$9.90 M(+4.2%)
Jun 1997
-
$2.80 M(+40.0%)
$9.50 M(+5.6%)
Mar 1997
-
$2.00 M(+17.6%)
$9.00 M(-1.1%)
Dec 1996
-
$1.70 M(-43.3%)
$9.10 M(+7.1%)
Sep 1996
$8.50 M(+28.8%)
$3.00 M(+30.4%)
$8.50 M(+11.8%)
Jun 1996
-
$2.30 M(+9.5%)
$7.60 M(+7.0%)
Mar 1996
-
$2.10 M(+90.9%)
$7.10 M(+4.4%)
Dec 1995
-
$1.10 M(-47.6%)
$6.80 M(+4.6%)
Sep 1995
$6.60 M(+34.7%)
$2.10 M(+16.7%)
$6.50 M(+1.6%)
Jun 1995
-
$1.80 M(0.0%)
$6.40 M(+10.3%)
Mar 1995
-
$1.80 M(+125.0%)
$5.80 M(+9.4%)
Dec 1994
-
$800.00 K(-60.0%)
$5.30 M(+6.0%)
Sep 1994
$4.90 M(+36.1%)
$2.00 M(+66.7%)
$5.00 M(+13.6%)
Jun 1994
-
$1.20 M(-7.7%)
$4.40 M(+4.8%)
Mar 1994
-
$1.30 M(+160.0%)
$4.20 M(+13.5%)
Dec 1993
-
$500.00 K(-64.3%)
$3.70 M(+5.7%)
Sep 1993
$3.60 M(+38.5%)
$1.40 M(+40.0%)
$3.50 M(+16.7%)
Jun 1993
-
$1.00 M(+25.0%)
$3.00 M(+11.1%)
Mar 1993
-
$800.00 K(+166.7%)
$2.70 M(+8.0%)
Dec 1992
-
$300.00 K(-66.7%)
$2.50 M(-7.4%)
Sep 1992
$2.60 M(+100.0%)
$900.00 K(+28.6%)
$2.70 M(+17.4%)
Jun 1992
-
$700.00 K(+16.7%)
$2.30 M(+15.0%)
Mar 1992
-
$600.00 K(+20.0%)
$2.00 M(+17.6%)
Dec 1991
-
$500.00 K(0.0%)
$1.70 M(+21.4%)
Sep 1991
$1.30 M(+160.0%)
$500.00 K(+25.0%)
$1.40 M(+40.0%)
Jun 1991
-
$400.00 K(+33.3%)
$1.00 M(+25.0%)
Mar 1991
-
$300.00 K(+50.0%)
$800.00 K(+14.3%)
Dec 1990
-
$200.00 K(+100.0%)
$700.00 K(+16.7%)
Sep 1990
$500.00 K(+400.0%)
$100.00 K(-50.0%)
$600.00 K(+50.0%)
Jun 1990
-
$200.00 K(0.0%)
$400.00 K(+100.0%)
Mar 1990
-
$200.00 K(+100.0%)
$200.00 K(-86.7%)
Dec 1989
-
$100.00 K(-200.0%)
$1.50 M(-48.3%)
Sep 1989
$100.00 K(-200.0%)
-$100.00 K(<-9900.0%)
$2.90 M(-341.7%)
Jun 1989
-
$0.00(-100.0%)
-$1.20 M(-700.0%)
Mar 1989
-
$1.50 M(0.0%)
$200.00 K(-300.0%)
Dec 1988
-
$1.50 M(-135.7%)
-$100.00 K(0.0%)
Sep 1988
-$100.00 K(-150.0%)
-$4.20 M(-400.0%)
-$100.00 K(-120.0%)
Jun 1988
-
$1.40 M(+16.7%)
$500.00 K(+66.7%)
Mar 1988
-
$1.20 M(-20.0%)
$300.00 K(-40.0%)
Dec 1987
-
$1.50 M(-141.7%)
$500.00 K(+150.0%)
Sep 1987
$200.00 K(-91.7%)
-$3.60 M(-400.0%)
$200.00 K(-85.7%)
Jun 1987
-
$1.20 M(-14.3%)
$1.40 M(-17.6%)
Mar 1987
-
$1.40 M(+16.7%)
$1.70 M(-15.0%)
Dec 1986
-
$1.20 M(-150.0%)
$2.00 M(-20.0%)
Sep 1986
$2.40 M(+41.2%)
-$2.40 M(-260.0%)
$2.50 M(-16.7%)
Jun 1986
-
$1.50 M(-11.8%)
$3.00 M(+11.1%)
Mar 1986
-
$1.70 M(0.0%)
$2.70 M(+22.7%)
Dec 1985
-
$1.70 M(-189.5%)
$2.20 M(+29.4%)
Sep 1985
$1.70 M
-$1.90 M(-258.3%)
$1.70 M(-52.8%)
Jun 1985
-
$1.20 M(0.0%)
$3.60 M(+50.0%)
Mar 1985
-
$1.20 M(0.0%)
$2.40 M(+100.0%)
Dec 1984
-
$1.20 M
$1.20 M

FAQ

  • What is Meridian Bioscience annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Meridian Bioscience?
  • What is Meridian Bioscience annual EBIT year-on-year change?
  • What is Meridian Bioscience quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Meridian Bioscience?
  • What is Meridian Bioscience quarterly EBIT year-on-year change?
  • What is Meridian Bioscience TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Meridian Bioscience?
  • What is Meridian Bioscience TTM EBIT year-on-year change?

What is Meridian Bioscience annual earnings before interest & taxes?

The current annual EBIT of VIVO is $55.51 M

What is the all time high annual EBIT for Meridian Bioscience?

Meridian Bioscience all-time high annual earnings before interest & taxes is $92.33 M

What is Meridian Bioscience annual EBIT year-on-year change?

Over the past year, VIVO annual earnings before interest & taxes has changed by -$36.82 M (-39.88%)

What is Meridian Bioscience quarterly earnings before interest & taxes?

The current quarterly EBIT of VIVO is $4.85 M

What is the all time high quarterly EBIT for Meridian Bioscience?

Meridian Bioscience all-time high quarterly earnings before interest & taxes is $36.88 M

What is Meridian Bioscience quarterly EBIT year-on-year change?

Over the past year, VIVO quarterly earnings before interest & taxes has changed by -$3.43 M (-41.42%)

What is Meridian Bioscience TTM earnings before interest & taxes?

The current TTM EBIT of VIVO is $55.51 M

What is the all time high TTM EBIT for Meridian Bioscience?

Meridian Bioscience all-time high TTM earnings before interest & taxes is $112.26 M

What is Meridian Bioscience TTM EBIT year-on-year change?

Over the past year, VIVO TTM earnings before interest & taxes has changed by -$36.82 M (-39.88%)